Jiangxi Fushine Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Jiangxi Fushine Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.31 Million ≈ $2.68 Million USD) by net assets (CN¥2.17 Billion ≈ $317.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)

Cash flow conversion efficiency of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. This chart illustrates how Jiangxi Fushine Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300497 live share price for real-time trading data and today's change.

Jiangxi Fushine Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Jiangxi Fushine Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jiangxi Fushine Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangxi Fushine Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Jiangxi Fushine Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
0.015x
Five Star Bancorp
NASDAQ:FSBC
0.050x
Taiyuan Heavy Industry Co Ltd
SHG:600169
0.080x
Smartgroup Corporation Ltd
AU:SIQ
0.253x
Medical Properties Trust, Inc.
NYSE:MPT
-0.003x
E2E Networks Limited
NSE:E2E
0.020x
Jiangsu Gian Technology Co Ltd
SHE:300709
0.215x
MAC Copper Ltd
AU:MAC
0.243x

Annual Cash Flow Conversion Efficiency for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. Review Jiangxi Fushine Pharmaceutical Co Ltd (300497) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.20 Billion
≈ $321.96 Million
CN¥62.67 Million
≈ $9.17 Million
0.028x -66.95%
2024-12-31 CN¥2.18 Billion
≈ $318.55 Million
CN¥187.64 Million
≈ $27.46 Million
0.086x +428.84%
2023-12-31 CN¥2.47 Billion
≈ $361.55 Million
CN¥-64.76 Million
≈ $-9.48 Million
-0.026x +41.66%
2022-12-31 CN¥2.69 Billion
≈ $393.58 Million
CN¥-120.85 Million
≈ $-17.68 Million
-0.045x -280.87%
2021-12-31 CN¥2.91 Billion
≈ $426.02 Million
CN¥72.32 Million
≈ $10.58 Million
0.025x -80.20%
2020-12-31 CN¥3.05 Billion
≈ $445.98 Million
CN¥382.35 Million
≈ $55.95 Million
0.125x -43.29%
2019-12-31 CN¥1.53 Billion
≈ $223.52 Million
CN¥337.91 Million
≈ $49.45 Million
0.221x +44.20%
2018-12-31 CN¥1.15 Billion
≈ $167.80 Million
CN¥175.91 Million
≈ $25.74 Million
0.153x -29.62%
2017-12-31 CN¥966.71 Million
≈ $141.46 Million
CN¥210.72 Million
≈ $30.84 Million
0.218x -9.34%
2016-12-31 CN¥784.17 Million
≈ $114.75 Million
CN¥188.53 Million
≈ $27.59 Million
0.240x +93.69%
2015-12-31 CN¥596.21 Million
≈ $87.24 Million
CN¥74.01 Million
≈ $10.83 Million
0.124x +12.02%
2014-12-31 CN¥283.26 Million
≈ $41.45 Million
CN¥31.39 Million
≈ $4.59 Million
0.111x -55.50%
2013-12-31 CN¥229.76 Million
≈ $33.62 Million
CN¥57.22 Million
≈ $8.37 Million
0.249x -27.25%
2012-12-31 CN¥184.60 Million
≈ $27.01 Million
CN¥63.20 Million
≈ $9.25 Million
0.342x +22.08%
2011-12-31 CN¥120.52 Million
≈ $17.64 Million
CN¥33.80 Million
≈ $4.95 Million
0.280x --

About Jiangxi Fushine Pharmaceutical Co Ltd

SHE:300497 China Biotechnology
Market Cap
$1.08 Billion
CN¥7.40 Billion CNY
Market Cap Rank
#8260 Global
#1877 in China
Share Price
CN¥13.73
Change (1 day)
-2.07%
52-Week Range
CN¥13.12 - CN¥23.34
All Time High
CN¥24.76
About

Jiangxi Fushine Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of APIs and pharmaceutical intermediates in China and internationally. It offers ß-lactamase inhibitors, carbapenem antibiotics, and antiviral drug intermediates; argatroban injection for the treatment of acute ischemic stroke; and doxycycline hydrochloride dispersi… Read more